Ras family GTPases are involved in a variety of physiological processes including cell growth, dierentiation, and malignant transformation (Barbacid, 1987; Katz and McCormick, 1997; Lowy and Willumsen, 1993) . Active Ras signals these events through GTP-dependent interactions with downstream eector molecules, such as the protein kinase Raf and the lipid kinase PI-3 kinase (Katz and McCormick, 1997) . The activity of Ras and related GTPases are positively regulated by guanine nucleotide exchange factors (GEFs) that function to promote the dissociation of GDP and binding of GTP to the GTPase (Cher®ls and Chardin, 1999) .
Activating mutations in Ras have been described in a variety of human cancers (Barbacid, 1987; Lowy and Willumsen, 1993) . These mutations, which include the G12V and Q61L mutations, result in a constitutively GTP-bound and therefore active form of Ras (Barbacid, 1987; Lowy and Willumsen, 1993) . These active mutants are used by investigators to mimic activation of endogenous Ras. Similarly, dominant interfering mutants of Ras, such as RasN17 and RasA15, are extensively used to determine whether a cellular process depends on Ras (Chen et al., 1994; Feig and Cooper, 1988; Mulcahy et al., 1985; Stacey et al., 1991) . Upon ectopic expression, these molecules can interfere with Ras activation by sequestering RasGEFs, thereby preventing them from activating endogenous Ras (Feig and Cooper, 1988; Stacey et al., 1991) .
We attempted to identify novel RasGEFs by searching for proteins that speci®cally interact with dominant negative Ras and puri®ed small G-protein GDP dissociation stimulator (smgGDS), an atypical GEF with multiple Armadillo (ARM) repeats (Yamamoto et al., 1990) . SmgGDS binds speci®cally to the dominant negative mutant (N17), but not to the constitutively active mutant (V12) of both H and NRas. In contrast to dominant negative Ras, smgGDS associates with the active and inactive forms of its known substrates, Rac1, Rap1a, RhoA and KRas and this appears to be mediated by the poly-basic Cterminal region of the GTPase, a motif not present in both H and NRas. The identi®cation of these unique interactions between smgGDS and small GTPases may suggest distinct modes by which smgGDS may regulate small GTPases. Furthermore, our observations indicate that many cellular responses observed with dominant negative Ras mutants, RasN17 and RasA15, could be due to sequestration of smgGDS.
Results and Discussion
Identification of smgGDS as an HRasN17 binding protein Dominant negative Ras mutants are common lab reagents that are used to determine if a cellular process is dependent on the activation of Ras. RasN17 and RasA15 are two such mutants that, when overexpressed, bind and sequester endogenous Ras exchange factors. Consequently, we used the binding properties of these mutants to isolate novel exchange factors of HRas. We searched for novel Ras exchange factors by using recombinant GST-HRasN17 as an anity matrix. To this end, 35 S-labeled COS1 whole cell extracts were incubated with recombinant GSTHRasN17 followed by extensive washing and elution with reduced glutathione. After SDS ± PAGE and autoradiography, we observed that a protein of 62 kDa co-puri®ed with GST-HRasN17, but not with GST-HRasV12 or GST (Figure 1a) . A 62 kDa protein was reproducibly detected in GST-HRasN17 pulldowns using a variety of cell lysates, including COS1, HeLa, MCF-7 and 293T (data not shown) as well as mouse brain.
In order to determine the identity of this protein, extracts from 30 mouse brains were applied to a GSTHRasN17 anity column. Following washing and elution we observed a 62 kDa band that puri®ed with GST-HRasN17 that was readily detected by Coomassie blue staining (Figure 1b ). This band was excised and subjected to protease digestion and Edman degradation which yielded the following two peptide sequences: KTGSDLMYL and KSVAQQAALTE, both of which were identical matches to amino acid sequences within the murine small GTPase guanine nucleotide dissociation stimulator (smgGDS) (Yamamoto et al., 1990) . Interestingly, smgGDS has previously been shown to function as a GEF on a subset of small GTPases, yet it bears no sequence homology to any known RasGEFs (Hiraoka et al., 1992; Mizuno et al., 1991) . We did not identify any known RasGEFs (e.g. SOS) in our anity puri®cation which may be attributed to the relative abundance of smgGDS compared to SOS, or to the binding avidity under these conditions.
To con®rm the interaction between smgGDS and HRasN17, we probed GST-HRasN17 pulldowns of 293 cell lysates with anti-GDS antibody. Consistent with our above results smgGDS was found to associate exclusively with HRasN17 ( Figure 1c, upper panel) . As a control, HRasV12 bound to Raf under identical conditions ( Figure 1c, lower panel) . Furthermore, HRasN17G37, an eector domain mutant (described below), no longer interacted with smgGDS. These results demonstrate that smgGDS selectively interacts with HRasN17 in vitro.
SmgGDS interacts with the nucleotide free form of HRas and NRas
SmgGDS bears no sequence homology to any known GEFs and was originally isolated as a protein able to stimulate GDP dissociation on the small GTPase Rap1 (Yamamoto et al., 1990) . Later biochemical characterization showed that smgGDS has unusual broad substrate speci®city and can stimulate nucleotide exchange on small GTPases, such as Rap1a, RhoA, K-Ras, Rac1, and Cdc42 (Mizuno et al., 1991) . Since we isolated smgGDS as protein capable of binding to dominant negative HRas, we reasoned that HRas would serve as a substrate for smgGDS, in contrast to previous reports (Hiraoka et al., 1992) . We directly tested smgGDS activity towards several GTPases using puri®ed, recombinant proteins. Consistent with earlier ®ndings we observed that RhoA (as well as Rac1 and Rac2, data not shown) served as substrates for smgGDS, while H and NRas did not (Mizuno et al., 1991) (Figure 1d ). This result is puzzling since the dominant negative forms of H, K, and NRas all associate with smgGDS to similar extents (see below) and would therefore be predicted to act as substrates for smgGDS.
One explanation for this observation is that dominant negative H and NRas binding to smgGDS is a gain-of-function associated with the mutant proteins only. We ruled out this possibility by using wild-type H and NRas stripped of nucleotide in binding assays with smgGDS. Neither GDP-nor GTPgS-loaded HRas interacted with recombinant His-smgGDS ( Figure 2a , left panel). HRas binding to smgGDS was observed only in the presence of EDTA. Similar results were observed with NRas ( Figure 2a , right panel). Since EDTA prevents nucleotide binding to small GTPases by chelation of magnesium, it is likely that smgGDS preferentially binds to the nucleotide free form of H and NRas. It appears from our results that the conformation adopted by the N17 conformation is the same as the nucleotide free conformation. This suggests that although complexed to GDP in vivo RasN17 most likely resides in a nucleotide free-like conformation (Stewart and Guan, 2000) . Alternatively, a fraction of RasN17 may exist in a nucleotide free form in vivo. Nevertheless, the observation that RasN17 adopts a nucleotide free conformation agrees with the model whereby GEFs promote exchange by binding and stabilizing the nucleotide free conformation of GTPases (Cher®ls and Chardin, 1999; Feig, 1999) .
When expressed together in 293T cells, HRasN17 coimmunoprecipitated with HA-smgGDS and the interaction of HA-smgGDS with HRasN17G37 (see below) was signi®cantly diminished (Figure 2b ). We also observed that HRasA15, another dominant negative mutant of Ras, associates more strongly with HAsmgGDS than does HRasN17 although it is expressed at signi®cantly lower levels than other Ras mutants ( Figure 2c ). HRasA15 displays a dramatically lower anity towards guanine nucleotide and it has been postulated that a signi®cant fraction of RasA15 exists in a nucleotide free form in vivo (Lai et al., 1993) . Therefore, the results are consistent with the model that smgGDS interacts with the nucleotide free form of Ras.
SmgGDS most likely uses a mechanism quite distinct from SOS to exchange upon KRas and other substrates (Nakanishi et al., 1994) . The switch II region of Ras is responsible for the interaction of Ras and SOS and an eector domain mutant in switch II (N69) known to abrogate the interaction with SOS still maintains S-Met/Cys as previously described (Stewart et al., 1999) . Cells were lysed in Buer T (20 mM Tris-Cl pH 7.5, 100 mM NaCl, 1 mM EGTA, 1 mM MgCl 2 , 0.2% Triton X-100, 10% glycerol) containing 1 mM DTT, 5 mM NaF, 1 mM NaVO 4 , and a protease inhibitor cocktail (Boehringer Mannheim) for this and subsequent experiments. Pre-cleared lysates were incubated for 2 h with 10 mg of recombinant GST, GST-HRasV12 or GST-HRasN17 pre-bound to glutathione-sepharose beads. GST fusion proteins were expressed in pGEX-KG and puri®ed as described previously (Self and Hall, 1995) . Beads were extensively washed followed by elution in buer containing 10 mM glutathione, followed by SDS ± PAGE and autoradiography. Bound proteins were analysed by SDS ± PAGE and visualized by autoradiography. The arrow (/) indicates the HRasN17 speci®c binding protein. (b) Puri®cation of an HRasN17 binding protein from mouse brain. For puri®cation of the 62 kDa band from mouse brain, a total of 20 ± 30 fresh mouse brains were isolated and immediately homogenized in Buer T. Brain extracts were incubated with 50 mg of GST-HRasN17 and puri®ed by glutathione sepharose. Proteins were eluted with glutathione and stained by Coomassie blue. Peptide digestion, HPLC puri®cation and sequencing has been described elsewhere (Stewart et al., 1999) . Left and right lanes are samples without and with brain lysates, respectively. The arrow (/) indicates the HRasN17 binding protein, and the asterisk (*) indicates GST-HRasN17. (c) HRasN17 interacts with endogenous smgGDS. 293T cell lysates were incubated with GST, GST-HRasV12, GST-HRasN17, or GST-HRasN17G37 precoupled to glutathione sepharose. The beads were washed several times and eluted in SDS sample buer. Samples were immunoblotted with a rabbit smgGDS antibody (upper panel). Puri®ed HissmgGDS protein was used to immunize rabbits for antibody production (Pocono Rabbit Farm & Laboratory Inc., Canadensis, PA, USA). Eluted proteins (GST fusion) were stained with Coomassie (middle panel). 293T cells transfected with cRaf (1 ± 269) were subjected to the same binding protocol as above. Samples were probed with anti-Raf (lower panel, Transduction Labs). All cells were maintained in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Transfections were performed using LipofectAMINE (Life Technologies) as recommended by the manufacturer. Immunoblots were performed essentially as described elsewhere (Stewart et al., 1999; Sugimoto et al., 1998) . (d) Recombinant smgGDS stimulates nucleotide exchange on RhoA, but not on HRas or NRas. Assays were performed as described (Chuang et al., 1994) . Brie¯y, in each assay tube 0.5 mg of either GST-HRas, GST-NRas, or GST-RhoA was preloaded with 3 H-GDP. pGEX-RhoA and pTrcHisB-GDS were generous gifts from G Bokoch (Scripps Institute) and J Lambeth (Emory University), respectively (Bowman et al., 1995; Chuang et al., 1994 ). The release of 3 H-GDP was monitored in the presence or absence of 5 or 10 mg of His-GDS and 250 mM GDP was used to initiate the reaction. An SDS ± PAGE of puri®ed recombinant proteins is presented (inset). SmgGDS stimulates the nucleotide exchange of RhoA but not HRas or NRas interaction with smgGDS (Quilliam et al., 1996) (Figure  3b ). Furthermore, smgGDS is the only known Armadillo repeat containing protein that exhibits any catalytic activity in light of the fact that it is composed almost entirely of Armadillo repeats which are common protein ± protein interaction motifs. Despite its GEF activity and ability to interact with dominant negative/ nucleotide free H and NRas, smgGDS is unable to promote exchange on these substrates. We would like to stress the uniqueness of the interaction between smgGDS and dominant negative Ras.
Active Ras interacts with its downstream targets via its eector domain which undergoes a signi®cant conformational change upon nucleotide binding (Katz and McCormick, 1997) . We reasoned that if the interaction between smgGDS and HRas depends on the conformation of HRas, mutations in the eector domain of HRas may eliminate its interaction with -agarose and MonoQ-ion exchange chromatography. GST-HRasN17 (5 mg) or GST-NRas (5 mg) was incubated with His-GDS (10 mg) in buer T. After 45 min, GSH-sepharose was added to recover the GTPase and associated smgGDS. Proteins were loaded with GTP-g-S or GDP as described previously (Chuang et al., 1994) . Where indicated, EDTA (30 mM) was included in the binding buer. Samples were probed with anti-smgGDS (upper panel). GST-fusion proteins used were detected by Coomassie staining (lower panel). (b) HRasN17 co-immunoprecipitates with smgGDS. pcDNA3-HA-GDS was constructed by ampli®cation of the smgGDS open reading frame from a human EST (accession #234764) and subcloned into pcDNA3-HA (Sugimoto et al., 1998) . The sequence was deposited in GenBank (accession #AF215293) as a novel splice form of smgGDS. All clones described were sequenced prior to use. The expression construct pcDNA3-Flag-cRaf-(1 ± 269) was a gift from R Jove (University of South Florida) (Pumiglia et al., 1995) . 293T cells were transfected with HA-smgGDS in the presence or absence of HRasN17 or HRasN17G37. Forty-eight hours posttransfection, lysates were subjected to immunoprecipitation (IP) with anti-HA (Babco) followed by Western blot (WB) with the indicated antibodies. (c) HRasA15 co-immunoprecipitates strongly with smgGDS. 293T cells were transfected with HA-smgGDS in the presence or absence of HRasN17, HRasN17G37 or HRasA15 and subject to the same IP protocol as in b Figure 3 Interaction between smgGDS and small GTPases. (a and b) SmgGDS interacts dierently with two classes of GTPases in a yeast two-hybrid assay. Two-hybrid analysis was carried out essentially as described elsewhere (Vojtek et al., 1993) . All GTPases contained the conserved C-terminal cysteine residue mutated to serine, with the exception of RhoV14 and RhoN19. pVP16-smgGDS was expressed as a full-length VP16 fusion. pVP16-smgGDS (1 ± 510) was constructed by PCR ampli®cation of residues 1 ± 510 of smgGDS. GDS (WT) represents the full-length clone (amino acid residues 1 ± 607), GDS (1 ± 510) represents a C-terminal deletion (residues 1 ± 510, i.e. the ®rst 10 Arm repeats). The baits NRasV12/K and NRasN17/K are chimeric molecules in which the last 14 residues of NRas have been replaced by the corresponding residues of KRas. Similarly for KRasV12/N, KRasN17/N and RhoAN19/H. ND, not determined. A positive interaction is denoted by growth on SC-LWH media, while +/7 indicates approximately 50% of full binding. PDE binds the C-terminus of Ras independently of its nucleotide binding state (S Stewart and K-L Guan, unpublished results). Included is a schematic of smgGDS. (c) HRasN17 does not aect the binding of RhoA to smgGDS. Binding reactions were set up essentially as in Figure 2a . (d) Alignment of the C-terminal 14 residues of various small GTPases illustrates two classes of C-termini. Positively charged residues are in boldface smgGDS. Therefore, a library of RasN17 was generated by random PCR mutagenesis followed by cloning into a two-hybrid bait vector. This library was introduced into a yeast strain harboring a VP16-smgGDS fusion protein. Two non-interacting mutants were isolated. DNA sequencing indicated that one class of mutants was likely due to the reversion of the conformational state of RasN17, where asparagine 17 was substituted by a lysine. The other class of mutants contained the substitution of glycine for glutamate at position 37 (Figure 2b,c) . Interestingly, E37 is located in the eector domain of Ras, which is known to be involved in the interaction with downstream targets (Katz and McCormick, 1997) .
SmgGDS interacts with KRas differently from HRas and NRas
SmgGDS interacted strongly with H and NRasN17, but not with the corresponding V12 mutants in the yeast two hybrid system (Figure 3a,b) . In contrast, smgGDS interacted with both KRasV12 and KRasN17 ( Figure  3b ). This suggests that the interaction of smgGDS with KRas is qualitatively dierent than with HRas and NRas and may re¯ect two distinct modes of binding. Others have observed that KRas can act as a substrate for smgGDS (Mizuno et al., 1991) while HRas and NRas do not (Figure 1d ), suggesting that smgGDS may interact with substrates in a conformation independent manner. This was further supported by the observation that smgGDS bound both the active and inactive mutants of known small GTPase substrates, including Rap1a, Rac1 and RhoA (Figure 3b) .
Additionally, deletion analysis of smgGDS also supports the hypothesis that smgGDS recognizes H and NRas in a manner dierent from its interaction with substrates ( Figure 3b) . Deletion of the C-terminal region of smgGDS (D511 ± 607) abolished its interaction with H and NRasN17, but retained its ability to interact with substrates. This suggests that the region encompassing ARM11 to the C-terminus is required for the binding of HRasN17 and NRasN17, yet is dispensable for binding its substrates. We also found that the binding of HRasN17 does not prevent the binding of RhoA ( Figure  3c ). Therefore, dierent regions of smgGDS are required for interactions with H and NRas as compared to its small GTPase substrates.
Given that smgGDS binds to dominant negative and nucleotide-free forms of H and NRas one would predict that they would indeed act as substrates for smgGDS. Similar modes of GTPase/GEF binding have been reported for`classical' exchange factors (Cher®ls and Chardin, 1999; Feig, 1999) . What makes smgGDS unique from other RasGEFs is that although it binds H and NRasN17, it does not promote exchange on H and NRas.
Role of the polybasic C-termini in small GTPases in binding and exchange by smgGDS Although KRas shares extremely high overall sequence identity with HRas and NRas, they dier in the amino acid sequence in the C-terminal regions. Speci®cally, H and NRas contain neutral C-termini in contrast to KRas, Rap1a, Rac1, and RhoA, which are very basic (Figure 3d ). It is well documented that ARM repeat containing proteins bind positive charge. Structural studies of the ARM repeat protein, karyopherin-a, in complex with a basic nuclear localization signal peptide, indicate the ability to bind basic peptides (Conti et al., 1998) . It therefore seemed possible that the basic C-terminus of small GTPases may participate in smgGDS binding and/or exchange activity.
We addressed this question by using a chimeric KRas molecule in which its C-terminus is replaced with that of NRas. This chimera, KRasV12/N, completely lost the ability to interact with smgGDS, but retained the ability to interact with a GTPdependent eector PI3K (Figure 3b) . Similarly, KRasN17/N was also unable to interact with smgGDS. We also replaced the C-terminal region of RhoA by the corresponding sequences of HRas and found that the RhoAN19/H chimera no longer bound to smgGDS. Conversely, if the C-terminus of NRas is replaced by that of KRas, the resulting chimeric molecule, NRasN17/K maintained the ability to bind smgGDS. In fact, NRasV12/K behaved as a gain of function mutant and interacted strongly with smgGDS ( Figure 3b) . Hence, the C-terminus of substrate molecules are necessary for interaction with smgGDS.
Initial studies indicated that smgGDS requires lipid modi®cation of the C-terminal Cys in the CAAX box of small GTPases for exchange activity (Mizuno et al., 1991) . However, a subsequent report indicated that the C-terminal lipid modi®cation of smgGDS substrates was not essential (Chuang et al., 1994) . We con®rm this observation by examining smgGDS stimulated exchange on E. Coli. expressed small GTPases whose C-terminus is not lipid modi®ed. To test the function of the C-terminal region of a smgGDS substrate, we constructed a chimera of RhoA with its C-terminus replaced with that of HRas (RhoA/H). In vitro RhoA/ H bound smgGDS weakly compared to wild-type RhoA (Figure 4a) . Furthermore, the RhoA/H chimera could not be exchanged upon by smgGDS ( Figure  4b,c) , suggesting that the positively charged RhoA Cterminus is essential for RhoA to serve as a substrate for smgGDS. A chimera consisting of HRas fused to a RhoA C-terminus was not an smgGDS substrate (Figure 4c ), indicating the basic C-terminal region is not sucient to confer exchange activity on HRas by smgGDS.
To investigate the functions of the C-terminal positively charged residues in RhoA, we mutated basic residues within the C-terminus of RhoA and found that mutation of Arg 182, 183 to alanines (RhoA-AA) maintained normal binding to smgGDS and maintained the ability to be exchanged upon (Figure 4a,c) . However, mutation of Lys 184, 185, 186 to alanines (RhoA-AAA) resulted in diminished binding to smgGDS and a decreased ability to be exchanged upon (Figure 4a,b,c) . Hence, these lysines are critical for the recognition and stimulation of exchange on RhoA by smgGDS.
Our data has shown that smgGDS is an exchange factor with distinct binding properties and exchange activities in vitro. We have identi®ed that two classes of GTPases exist that bind smgGDS, however only one of these classes is capable of being exchanged upon. This prompted the question of whether one GTPase aects the activity of another. It is possible that smgGDS activity is regulated by RasN17, which may contribute to the many phenotypes elicited by dominant negative Ras (Feig and Cooper, 1988) (Stewart and Guan, 2000) . We observed that in vivo HRasN17 was able to inhibit the GTP loading of RhoA (Figure 4d ). Whether this occurs through endogenous smgGDS is a question we are currently pursuing.
Under our conditions we did not observe in vivo activation of RhoA by smgGDS (Figure 4d ) which questions whether smgGDS functions as an exchange factor in vivo. Nevertheless our data indicate that Figure 2a . RhoA/H is a chimeric molecule in which the last 14 aa were replaced by that of HRas. RhoA-AA and RhoA-AAA correspond to RhoA (R182A, R183A) and RhoA (K185A,K186A,K187A), respectively. (b) Time course of smgGDS stimulation of RhoA mutants. RhoA, RhoA/H and RhoA-AAA (2 mg) were used as substrates for smgGDS (10 mg) and GDP release was monitored over time as described in Figure 1d . (c) Concentration dependence of smgGDS stimulation on RhoA mutants. RhoA, RhoA/H, RhoA-AA, RhoA-AAA and HRas/R (2 mg) were used as substrates with varying concentrations of smgGDS for 60 min. HRas/R corresponds to a chimeric molecule in which the C-terminal 12 aa of HRas was replaced by those of RhoA. (d) HRasN17 inhibits RhoA activation and smgGDS does not stimulate RhoA exchange. 293T cells were transfected with myc-RhoA (provided by A Hall, University College London, London, UK), myc-smgGDS (provided by Y Takai, Osaka University Medical School, Japan) and HRasN17. Forty-eight hours posttransfection cells were starved for phosphate in DMEM (7 phosphate) + 10% dialyzed FBS for 3 h and labeled in the same media with 0.5 mCi/mL 32 P-orthophosphate (ICN) for 4 h. Cells were lysed in 50 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM MgCl 2 , 1% TX-100, 1 mg/mL BSA, 1 mM DTT, 1 mM PMSF. Cell lysates were cleared by centrifugation, NaCl was added to 500 mM and mycRho was immunoprecipitated with a-myc9E10 (Babco)/protein G-sepharose beads for 1 h. Beads were collected and washed extensively in the above buer. Bound nucleotide was eluted with 2 mM EDTA, 0.2% SDS, 1 mM GDP, 1 mM GMPPNP at 688C for 20 min. Eluted nucleotide was spotted on PEI-cellulose (JT Baker), subject to thin layer chromatography in 1 M LiCl and exposed to a phosphorimager plate overnight caution should be taken in interpreting results based on dominant negative mutants of Ras. Our observations suggest that cellular eects of dominant negative mutants of a small GTPase may not solely be due to interference with activation of the endogenous GTPase, but could be due to misregulation of other GTPases.
Abbreviations GDS, GDP dissociation stimulator; GEF, Guanine nucleotide exchange factor; ARM, Armadillo; GTPgS, guanosine 5'-3-O-(thio)triphosphate; PAGE, polyacrylamide gel electrophoresis.
